Cargando…

Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital

This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an el...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeana, Cosmina, Palmieri, Frank E., Gupta, Vikas, Ye, Gang, Lao, Peter, Yu, Kalvin, Kang, Kyoung-Sil, Schiller, Larry, Purswani, Murli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455014/
https://www.ncbi.nlm.nih.gov/pubmed/33908291
http://dx.doi.org/10.1177/00368504211011876
_version_ 1785096347567783936
author Zeana, Cosmina
Palmieri, Frank E.
Gupta, Vikas
Ye, Gang
Lao, Peter
Yu, Kalvin
Kang, Kyoung-Sil
Schiller, Larry
Purswani, Murli
author_facet Zeana, Cosmina
Palmieri, Frank E.
Gupta, Vikas
Ye, Gang
Lao, Peter
Yu, Kalvin
Kang, Kyoung-Sil
Schiller, Larry
Purswani, Murli
author_sort Zeana, Cosmina
collection PubMed
description This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an electronic medical record algorithm that prompted physicians to re-evaluate FQ use shortly after admission and changed institutional UTI/pneumonia guidelines that recommended options alternate to FQs for first-line empiric antibiotic therapy in 2010 and 2011 respectively. Between 2007 and 2017 FQ use and ciprofloxacin susceptibilities of all non-duplicate cultured isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa obtained ≥72 h after admission were reviewed. Ambulatory care isolates served as a comparison group. FQ utilization rates and relationships to ciprofloxacin susceptibility were evaluated using interrupted time series models. Over the 11-year period, FQ use decreased from 110.0 (2007) to 26.2 (2017) days of therapy/1000 days at risk (p < 0.001). Compared to pre-intervention, the estimated (post-intervention) reduction in FQ utilization was 28.4 (95% CI: 10.9–46) days of therapy/1000 days at risk. Reduced FQ utilization was correlated with increase susceptibilities to ciprofloxacin of hospital onset isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis (p < 0.02), and Pseudomonas aeruginosa (p = 0.07). No significant susceptibility change was observed in the ambulatory care isolates. Persuasive interventions by an ASP successfully modified physicians’ inpatient empiric antibiotic use, produced a sustained reduction in FQ utilization rates and increased ciprofloxacin susceptibility to four commonly encountered gram-negative bacteria in a community hospital.
format Online
Article
Text
id pubmed-10455014
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-104550142023-08-26 Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital Zeana, Cosmina Palmieri, Frank E. Gupta, Vikas Ye, Gang Lao, Peter Yu, Kalvin Kang, Kyoung-Sil Schiller, Larry Purswani, Murli Sci Prog Short Reports This study evaluated an antibiotic stewardship program (ASP) intervention aimed at reducing inpatient fluoroquinolone (FQ) use and examined its impact on ciprofloxacin susceptibilities of gram-negative bacteria in a large 611-bed community hospital. A two-step ASP intervention was implemented: an electronic medical record algorithm that prompted physicians to re-evaluate FQ use shortly after admission and changed institutional UTI/pneumonia guidelines that recommended options alternate to FQs for first-line empiric antibiotic therapy in 2010 and 2011 respectively. Between 2007 and 2017 FQ use and ciprofloxacin susceptibilities of all non-duplicate cultured isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa obtained ≥72 h after admission were reviewed. Ambulatory care isolates served as a comparison group. FQ utilization rates and relationships to ciprofloxacin susceptibility were evaluated using interrupted time series models. Over the 11-year period, FQ use decreased from 110.0 (2007) to 26.2 (2017) days of therapy/1000 days at risk (p < 0.001). Compared to pre-intervention, the estimated (post-intervention) reduction in FQ utilization was 28.4 (95% CI: 10.9–46) days of therapy/1000 days at risk. Reduced FQ utilization was correlated with increase susceptibilities to ciprofloxacin of hospital onset isolates of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis (p < 0.02), and Pseudomonas aeruginosa (p = 0.07). No significant susceptibility change was observed in the ambulatory care isolates. Persuasive interventions by an ASP successfully modified physicians’ inpatient empiric antibiotic use, produced a sustained reduction in FQ utilization rates and increased ciprofloxacin susceptibility to four commonly encountered gram-negative bacteria in a community hospital. SAGE Publications 2021-04-28 /pmc/articles/PMC10455014/ /pubmed/33908291 http://dx.doi.org/10.1177/00368504211011876 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Short Reports
Zeana, Cosmina
Palmieri, Frank E.
Gupta, Vikas
Ye, Gang
Lao, Peter
Yu, Kalvin
Kang, Kyoung-Sil
Schiller, Larry
Purswani, Murli
Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title_full Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title_fullStr Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title_full_unstemmed Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title_short Association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: Results from an 8-year intervention by an antibiotic stewardship program in an inner-city United States hospital
title_sort association between fluoroquinolone utilization rates and susceptibilities of gram-negative bacilli: results from an 8-year intervention by an antibiotic stewardship program in an inner-city united states hospital
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455014/
https://www.ncbi.nlm.nih.gov/pubmed/33908291
http://dx.doi.org/10.1177/00368504211011876
work_keys_str_mv AT zeanacosmina associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT palmierifranke associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT guptavikas associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT yegang associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT laopeter associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT yukalvin associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT kangkyoungsil associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT schillerlarry associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital
AT purswanimurli associationbetweenfluoroquinoloneutilizationratesandsusceptibilitiesofgramnegativebacilliresultsfroman8yearinterventionbyanantibioticstewardshipprograminaninnercityunitedstateshospital